Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. - Wikidata - wikimedia - TriplyDB

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

http://www.wikidata.org/entity/Q43446974

about

Gastrointestinal cancers in the era of theranostics: Updates and future perspectives Management of patients with hepatic metastases from neuroendocrine tumors Favourable outcomes of (177)Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment Stratification The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis.Solid neuroendocrine breast carcinoma: mammographic and sonographic features in thirteen cases.Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.Real-world study of everolimus in advanced progressive neuroendocrine tumors.Expression of IMP3 as a marker for predicting poor outcome in gastroenteropancreatic neuroendocrine neoplasms.Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.Duodenal gangliocytic paraganglioma showing lymph node metastasis: a rare case report.Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Gastric neuroendocrine tumours.The role of chemotherapy and/or octreotide in patients with metastatic gastroenteropancreatic and hepatobiliary neuroendocrine carcinoma Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT Bilocal recurrence of a neuroendocrine carcinoma of the small intestine: A case report.Transplantation and surgical strategies in patients with neuroendocrine liver metastases: protocol of four systematic reviews.Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report.Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors.Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis Aggressive Locoregional Treatment Improves the Outcome of Liver Metastases from Grade 3 Gastroenteropancreatic Neuroendocrine Tumors Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation.Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study.The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs.A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution.Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.Sequelae and survivorship in patients treated with (131)I-MIBG therapy Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database.Bone metastases in GEP-NET: response and long-term outcome after PRRT from a follow-up analysis.Histological characterisation and prognostic evaluation of 62 gastric neuroendocrine carcinomas.Chromogranin A, Ki-67 index and IGF-related genes in patients with neuroendocrine tumors.May bone-targeted radionuclide therapy overcome PRRT-refractory osseous disease in NET? A pilot report on (188)Re-HEDP treatment in progressive bone metastases after (177)Lu-octreotate.Early diagnosis and treatment of gastrointestinal neuroendocrine tumors.A woman with metastatic pancreatic neuroendocrine tumor.

P2860

Q26801215-B36CD765-58D8-4429-BDEF-01E5A15897B6 Q27008832-F8F474F0-E146-4897-BFF8-FB71FE27FA0A Q28247667-C01889A0-36AE-4D96-87FA-F0F4C79073E0 Q28551275-E5FC0F99-8AE5-4CCA-A82D-D7D3D164F0DB Q30252003-FBD94A01-0F10-4F4B-8744-4C5BB51D7BDF Q30445932-439A7810-AAEF-40D3-8997-042B285A9F08 Q30884528-8F76FF0E-4D35-43EE-88E1-E307E06CFDBD Q31095566-F0EFD00C-EAA6-4415-AD75-75FC76C8841D Q33417013-D1799D83-BFC7-454D-8570-85B5DA62AFC7 Q33598498-1B75F830-C422-432A-9913-27D1779A6C30 Q33658301-3B037A3B-AE43-4BC5-9CED-E6E1EEB3B505 Q33782024-9B381294-12C6-4BC7-96D5-E4706E897518 Q33783119-201C0D08-BC45-4332-BDBD-185E579AF1FE Q33870146-DAE1B466-6CC8-46B6-9C0B-8918697EED6C Q33901099-24483B72-227A-4996-851B-BFCCF4867E1D Q34248487-98490515-55CC-41AA-8C0B-8782D8FC56C5 Q34306680-14B9CF73-18CB-4918-A887-751DA85909CE Q34484273-09619787-6B5E-405C-AAA8-AEA2DEC0D10E Q34503869-A2156C08-16DF-43ED-9BEE-617FD4C40603 Q34768375-BC0173F7-B689-46EB-B14F-5839DA17D739 Q35074937-FBF17B07-500B-4CB9-8618-82BAA03A1194 Q35274974-83E5FC88-30B0-4C3D-BB05-81AEA1A8FBE9 Q35284530-3B3CE48C-0C3D-43FA-AE38-1A4BE9583A52 Q35895493-ED85A461-FAEB-4B63-97B8-6071FC430DB5 Q35934630-796C705F-45C5-40F4-B1E5-C01CA497BF02 Q36153131-9C1E1385-95A5-4953-9D86-2DD6E46128BB Q36335121-9B603EBA-694C-404D-BAF9-05AF4EB5E371 Q36344419-D3ECDD25-D7F1-4B72-AE44-F02BEA643CED Q36657306-CC7E5CA6-9C86-4943-ACD3-3F67679CE473 Q36857533-E4EEFB19-B686-4F31-B0F9-E73BD8801314 Q36993386-4EAD3A7B-BF7C-42F4-9F0A-99DE2B631B40 Q37056120-0B2FE9A6-9851-499A-B719-79B42AB03C45 Q37081870-4B6C9D7B-27D9-43EB-8965-F9DC0A4418C8 Q37085554-B36BE781-CCF7-4B9A-A6F7-DC330AAD7A70 Q37201458-EC2C3B58-361F-4F87-82E8-DB9F824684D3 Q37274363-8859AD85-2683-4F2D-8E88-0234C87CD67B Q37358231-1A0F3CC3-FA9B-4248-AFAD-7DB8F4922923 Q37402627-4F3F981B-E2AB-4938-8549-39EA74A11E5A Q37406973-160F4BC2-B105-4FCC-A288-C3C8852690CF Q37584857-8C0EF3AD-2EA7-4758-B27A-D7336A805328

P2860

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

http://www.wikidata.org/entity/Q43446974

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

@en

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

@nl

type

label

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

@en

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

@nl

prefLabel

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

@en

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

@nl

P1433

Q43446974-69A1D393-FB53-4C7A-B136-F5B42ADD773B

P1476

Q43446974-C88FDD55-43C0-495F-B150-701C05ECBB86

P2093

Q43446974-01474951-7F38-45BF-803E-43C5DD0D437B

Q43446974-50E07B2C-3555-4FF6-B02E-95DF0C108D73

Q43446974-6C90324B-CC11-4BBA-8078-5B40434B4639

Q43446974-966A119B-E6E5-4D0F-BC28-23503D50FE1A

Q43446974-9D894ABE-C378-42CB-B132-4E013F6756C9

Q43446974-AF5BB7A5-748B-45D3-B693-F976C5551221

Q43446974-BBE2B120-D4D1-49EC-B65B-10926F78B96B

P304

Q43446974-0E20DF5F-602A-44A2-8177-3A8C6D2609AC

P31

Q43446974-4E3CE621-407F-4AF0-A7BC-EFE6DE6C3BF1

P356

Q43446974-608C0138-1BDF-4A7F-A131-275FD1D061C2

P433

Q43446974-092A264D-64D2-4CCF-99AF-A8225C39E44E

P478

Q43446974-54394375-641B-4BF5-BC14-BCC4167FACF1

P50

Q43446974-8CF38238-A646-47AC-9F36-929B133DA096

P577

Q43446974-391AA5B9-E6BE-486F-9F80-39A02443124F

P5875

Q43446974-FB79F537-61B0-4453-AF23-93E961685464

P698

Q43446974-CC32E344-1566-483E-9612-F3933487F35A

P356

P1433

Endocrine-related cancer

P1476

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.

@en

P2093

Bertram Wiedenmann

http://www.w3.org/2001/XMLSchema#string

Martin Koch

http://www.w3.org/2001/XMLSchema#string

Michael Böhmig

http://www.w3.org/2001/XMLSchema#string

Stefan N Willich

http://www.w3.org/2001/XMLSchema#string

Stephanie Roll

http://www.w3.org/2001/XMLSchema#string

Ulrich-Frank Pape

http://www.w3.org/2001/XMLSchema#string

Uta Berndt

http://www.w3.org/2001/XMLSchema#string

P304

1083-1097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1677/ERC-08-0017

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Jacqueline Müller-Nordhorn

P577

2008-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5248727

http://www.w3.org/2001/XMLSchema#string

P698

18603570

http://www.w3.org/2001/XMLSchema#string